Published on:

Pharmaceutical company to pay $425 Million for improper marketing

In a serious case of products liability, drug maker Cephalon, Inc. will pay $425 million in a settlement for illegally marketing a highly addictive lollipop painkiller and two other pharmaceuticals for non-approved uses. The company will plead to a criminal misdemeanor for its off-label marketing. The drug was marketed to doctors for maladies including migraines and injuries when it was a highly addictive narcotic approved only for cancer patients with severe pain.

For the full article.